Brainstorm Cell Therapeutics (BCLI) Misses Q3 EPS by 19c

Brainstorm Cell Therapeutics (NASDAQ: BCLI) reported Q3 EPS of ($0.19).

For earnings history and earnings-related data on Brainstorm Cell Therapeutics (BCLI) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• Tesla (TSLA) call put ratio 1.2 calls to 1 put with a focus on 1500 contracts of September 100 puts
• Home Depot (HD) call put ratio 1 call to 1.8 puts with a focus on August 332.5 puts into quarter results